Clinical Trial Update: Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a fixed-ratio insulin glargine/lixisenatide combination versus insulin glargine alone and lixisenatide alone…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Lixisenatide (lixisenatide)
• iGlarLixi (insulin glargine/lixisenatide) fixed-ratio combination (insulin glargine / lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2017-02-10